Skip to content
PubMed This is a summary of 111 peer-reviewed journal articles Updated
Oncology

Diffuse Gastric Adenocarcinoma: A Comprehensive Guide

At a Glance

Diffuse gastric adenocarcinoma is a distinct form of stomach cancer requiring specialized care, including perioperative chemotherapy and D2 lymphadenectomy. Biomarker testing for the CDH1 gene and CLDN18.2 is crucial to guide targeted therapies, manage hereditary risks, and personalize treatment.

A diagnosis of diffuse gastric adenocarcinoma brings a flood of medical terms, complex decisions, and understandable anxiety. Because this specific type of stomach cancer behaves differently than the more common intestinal type, it requires a specialized approach to diagnosis and treatment.

This guide was created to empower you with evidence-based information, translating complex medical data into a clear, strategic roadmap. Our goal is to help you understand your diagnosis, ask the right questions, and partner effectively with your medical team. You do not have to read everything at once. Start where you are in your journey and take it one step at a time.

Navigating This Guide

Remember, this resource is here to inform and empower you. Always discuss your specific situation, preferences, and treatment options with your specialized medical team.

Common questions in this guide

What is diffuse gastric adenocarcinoma?
Diffuse gastric adenocarcinoma is a specific type of stomach cancer that behaves and spreads differently than the more common intestinal type. Instead of forming a solid mass, it often spreads diffusely through the stomach wall, requiring specialized tools like endoscopic ultrasound and laparoscopy for accurate diagnosis.
Why is genetic testing recommended for diffuse gastric cancer?
Genetic testing is important because some diffuse gastric cancers are linked to hereditary mutations, specifically in the CDH1 gene. Identifying this mutation can help guide your surgical decisions and determine if your family members should also undergo genetic counseling and testing.
How is localized diffuse gastric cancer treated?
The standard of care for localized disease typically involves a "sandwich" approach, meaning perioperative chemotherapy is given both before and after surgery. The surgical gold standard for this cancer is a highly specialized procedure called a D2 lymphadenectomy, which removes the stomach and surrounding lymph nodes.
Which biomarker tests should be done for advanced diffuse stomach cancer?
For advanced disease, your tumor should be tested for several key biomarkers including CLDN18.2, HER2, and PD-L1. These test results help your oncology team determine if you are a candidate for specific targeted therapies, such as zolbetuximab, or immunotherapy treatments.
What is life like after surgery for stomach cancer?
Life after a partial or total gastrectomy involves significant adjustments, especially regarding nutrition. Patients typically work closely with a dietitian to learn how to eat small, frequent meals, maintain their weight, and manage post-surgery conditions like dumping syndrome.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific diagnosis, which parts of this guide should I focus on first?
  2. 2.Who will be the primary coordinator of my care team among the surgeon, oncologist, and dietitian?
  3. 3.Are there any clinical trials for diffuse gastric adenocarcinoma that might be appropriate for my stage?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This diffuse gastric adenocarcinoma guide is for educational purposes only. Always consult your specialized oncology team to discuss your specific diagnosis, genetic risks, and treatment options.

Get notified when new evidence is published on diffuse gastric adenocarcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.